CCC
IMMX icon

Cable Car Capital’s Immix Biopharma IMMX Stock Holding History

Cable Car Capital’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-779,358
Closed -$1.31M – 69
2025
Q1 		$1.31M Sell
779,358
-16,742
-2% -$31.6K 1.49% 25
2024
Q4 		$1.75M Hold
796,100
– – 0.07% 53
2024
Q3 		$1.19M Hold
796,100
– – 1.27% 24
2024
Q2 		$1.58M Buy
796,100
+125,642
+19% +$289K 1.66% 19
2024
Q1 		$2.06M Buy
+670,458
New +$2.6M 2.84% 15

Other funds holding IMMX

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Cable Car Capital's IMMX Position: Q2 2025 in Review

Cable Car Capital sold out of Immix Biopharma (IMMX) in Q2 2025, closing a stake of 779,358 shares — an estimated $1.31M sold.

Cable Car Capital first reported a position in IMMX in Q1 2024 and held it in 5 quarters. The position peaked at $2.06M in Q1 2024. 23 funds tracked by Wall St. Rank hold IMMX as of Q2 2025.

  • Cable Car Capital reported no remaining Immix Biopharma position as of Q2 2025 after selling out during the quarter.
  • Cable Car Capital sold 779,358 Immix Biopharma shares in Q2 2025, an estimated $1.31M.
  • Cable Car Capital first reported a position in Immix Biopharma in Q1 2024 and held it in 5 quarters.
  • Cable Car Capital's Immix Biopharma position peaked at $2.06M in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2025.

Based on Cable Car Capital's 13F filing for Q2 2025, filed 14 Aug 2025.